Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Bio-Techne Corporation

TECHNASDAQ
Healthcare
Biotechnology
$58.25
$0.00(0.00%)
U.S. Market is Open • 14:02

Bio-Techne Corporation (TECH) Stock Overview

Explore Bio-Techne Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9B
P/E Ratio109.69
EPS (TTM)$0.53
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$55.03
3 Months$49.59
1 Year Target$51.60

TECH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Techne Corporation (TECH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $51.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 109.69 and a market capitalization of 9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.25%
5-Day Change
-3.51%
1-Month Change
-17.32%
3-Month Change
-2.06%
6-Month Change
5.87%
Year-to-Date (YTD) Change
-3.57%
1-Year Change
-12.17%
3-Year Change
-21.91%
5-Year Change
-38.97%
All-Time (Max) Change
52487.31%

Contact Information

612 379 8854
614 McKinley Place N.E., Minneapolis, MN, 55413

Company Facts

31,000 Employees
IPO DateFeb 9, 1989
CountryUS
Actively Trading

Frequently Asked Questions